{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=AS+MDI", "query": { "intervention": "AS MDI" }, "page_size": 10 }, "pagination": { "page": 1, "page_size": 10, "total_count": 126, "total_pages": 13, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=AS+MDI&page=2&page_size=10", "previous_page_url": null }, "source": "remote", "last_synced_at": "2026-09-04T03:44:20.177Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT02040766", "title": "A Safety and Efficacy Study of Beclomethasone Dipropionate Delivered Via Breath-Actuated Inhaler (BAI) or Metered-Dose Inhaler (MDI) in Participants Ages 4-11 Years Old With Persistent Asthma", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Asthma" ], "interventions": [ { "name": "Beclomethasone dipropionate BAI", "type": "DRUG" }, { "name": "Placebo BAI", "type": "DRUG" }, { "name": "albuterol/salbutamol 90 mcg", "type": "DRUG" }, { "name": "Beclomethasone dipropionate MDI", "type": "DRUG" }, { "name": "Placebo MDI", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Teva Branded Pharmaceutical Products R&D, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "4 Years", "maximum_age": "11 Years", "sex": "ALL", "summary": "4 Years to 11 Years" }, "enrollment_count": 628, "start_date": "2013-12", "completion_date": "2016-03", "has_results": true, "last_update_posted_date": "2021-11-09", "last_synced_at": "2026-09-04T03:44:20.177Z", "location_count": 75, "location_summary": "Hoover, Alabama • Montgomery, Alabama • Phoenix, Arizona + 62 more", "locations": [ { "city": "Hoover", "state": "Alabama" }, { "city": "Montgomery", "state": "Alabama" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Little Rock", "state": "Arkansas" }, { "city": "Costa Mesa", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT02040766" }, { "nct_id": "NCT05505734", "title": "A Comparison of PT027 vs PT007 Used as Needed in Participants With Asthma", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Asthma" ], "interventions": [ { "name": "BDA MDI", "type": "DRUG" }, { "name": "AS MDI", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Bond Avillion 2 Development LP", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "12 Years", "maximum_age": null, "sex": "ALL", "summary": "12 Years and older" }, "enrollment_count": 2516, "start_date": "2022-09-02", "completion_date": "2024-08-22", "has_results": true, "last_update_posted_date": "2025-08-03", "last_synced_at": "2026-09-04T03:44:20.177Z", "location_count": 61, "location_summary": "Mobile, Alabama • Paradise Valley, Arizona • Tempe, Arizona + 50 more", "locations": [ { "city": "Mobile", "state": "Alabama" }, { "city": "Paradise Valley", "state": "Arizona" }, { "city": "Tempe", "state": "Arizona" }, { "city": "Bakersfield", "state": "California" }, { "city": "Culver City", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT05505734" }, { "nct_id": "NCT06644924", "title": "A Study Evaluating the Effect of Inhaled PT007(AS MDI) Versus Placebo MDI and Ventolin Evohaler on Lung Function in Adult Participants With Asthma", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Asthma" ], "interventions": [ { "name": "Intervention: AS MDI", "type": "COMBINATION_PRODUCT" }, { "name": "Intervention: Ventolin Evohaler", "type": "COMBINATION_PRODUCT" }, { "name": "Intervention: Placebo matching AS MDI", "type": "COMBINATION_PRODUCT" } ], "intervention_types": [ "COMBINATION_PRODUCT" ], "sponsor": "AstraZeneca", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "18 Years to 65 Years" }, "enrollment_count": 118, "start_date": "2025-02-10", "completion_date": "2025-06-04", "has_results": true, "last_update_posted_date": "2026-08-27", "last_synced_at": "2026-09-04T03:44:20.177Z", "location_count": 22, "location_summary": "Encinitas, California • Lancaster, California • Los Angeles, California + 19 more", "locations": [ { "city": "Encinitas", "state": "California" }, { "city": "Lancaster", "state": "California" }, { "city": "Los Angeles", "state": "California" }, { "city": "Newport Beach", "state": "California" }, { "city": "San Diego", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT06644924" }, { "nct_id": "NCT03012061", "title": "Phase IIb Study of Umeclidinium (UMEC) Bromide Versus Placebo in Subjects With Asthma", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Asthma" ], "interventions": [ { "name": "Placebo", "type": "DRUG" }, { "name": "UMEC", "type": "DRUG" }, { "name": "Fluticasone Furoate", "type": "DRUG" }, { "name": "Albuterol/salbutamol", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "GlaxoSmithKline", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 425, "start_date": "2017-01-25", "completion_date": "2018-05-30", "has_results": true, "last_update_posted_date": "2020-10-28", "last_synced_at": "2026-09-04T03:44:20.177Z", "location_count": 19, "location_summary": "Tempe, Arizona • Rolling Hills Estates, California • Colorado Springs, Colorado + 15 more", "locations": [ { "city": "Tempe", "state": "Arizona" }, { "city": "Rolling Hills Estates", "state": "California" }, { "city": "Colorado Springs", "state": "Colorado" }, { "city": "Topeka", "state": "Kansas" }, { "city": "Natchitoches", "state": "Louisiana" } ], "official_url": "https://clinicaltrials.gov/study/NCT03012061" }, { "nct_id": "NCT01980615", "title": "Phase I Study Evaluating the Safety and Pharmacokinetics of Budesonide, Glycopyrronium, and Formoterol Fumarate Inhalation Aerosol (BGF MDI) in Healthy Volunteers", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Healthy Volunteers" ], "interventions": [ { "name": "Inhaled BGF (PT010) Dose 1", "type": "DRUG" }, { "name": "Inhaled BGF (PT010) Dose 2", "type": "DRUG" }, { "name": "Inhaled BGF (PT010) Dose 3", "type": "DRUG" }, { "name": "Inhaled GFF (PT003)", "type": "DRUG" }, { "name": "Inhaled Symbicort Dose 1", "type": "DRUG" }, { "name": "Inhaled Symbicort Dose 2", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Pearl Therapeutics, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "45 Years", "sex": "ALL", "summary": "18 Years to 45 Years" }, "enrollment_count": 84, "start_date": "2013-11", "completion_date": "2013-12", "has_results": false, "last_update_posted_date": "2014-04-14", "last_synced_at": "2026-09-04T03:44:20.177Z", "location_count": 1, "location_summary": "Baltimore, Maryland", "locations": [ { "city": "Baltimore", "state": "Maryland" } ], "official_url": "https://clinicaltrials.gov/study/NCT01980615" }, { "nct_id": "NCT06307665", "title": "Evaluating the Efficacy and Safety of PT027 Compared With PT007 Administered As Needed in Participants 12 to < 18 Years of Age With Asthma", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Asthma" ], "interventions": [ { "name": "BDA MDI", "type": "COMBINATION_PRODUCT" }, { "name": "AS MDI", "type": "COMBINATION_PRODUCT" } ], "intervention_types": [ "COMBINATION_PRODUCT" ], "sponsor": "AstraZeneca", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "12 Years", "maximum_age": "17 Years", "sex": "ALL", "summary": "12 Years to 17 Years" }, "enrollment_count": 440, "start_date": "2024-05-20", "completion_date": "2027-10-13", "has_results": false, "last_update_posted_date": "2026-08-13", "last_synced_at": "2026-09-04T03:44:20.177Z", "location_count": 113, "location_summary": "Anchorage, Alaska • Gilbert, Arizona • Phoenix, Arizona + 91 more", "locations": [ { "city": "Anchorage", "state": "Alaska" }, { "city": "Gilbert", "state": "Arizona" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Little Rock", "state": "Arkansas" }, { "city": "Huntington Beach", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT06307665" }, { "nct_id": "NCT02196714", "title": "PK Study of PT003 and PT001 in Japanese Healthy Subjects", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "COPD" ], "interventions": [ { "name": "Glycopyrronium and Formoterol Fumarate (GFF) Dose 1", "type": "DRUG" }, { "name": "Glycopyrronium and Formoterol Fumarate (GFF) Dose 2", "type": "DRUG" }, { "name": "Glycopyrronium (GP) Dose 1", "type": "DRUG" }, { "name": "Glycopyrronium (GP) Dose 2", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Pearl Therapeutics, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "45 Years", "sex": "ALL", "summary": "18 Years to 45 Years" }, "enrollment_count": 24, "start_date": "2014-07", "completion_date": null, "has_results": true, "last_update_posted_date": "2017-04-26", "last_synced_at": "2026-09-04T03:44:20.177Z", "location_count": 1, "location_summary": "Baltimore, Maryland", "locations": [ { "city": "Baltimore", "state": "Maryland" } ], "official_url": "https://clinicaltrials.gov/study/NCT02196714" }, { "nct_id": "NCT01349816", "title": "PT003 MDI Dose Confirmation Study", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Chronic Obstructive Pulmonary Disease" ], "interventions": [ { "name": "PT003", "type": "DRUG" }, { "name": "PT001", "type": "DRUG" }, { "name": "PT005", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Pearl Therapeutics, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "40 Years", "maximum_age": "80 Years", "sex": "ALL", "summary": "40 Years to 80 Years" }, "enrollment_count": 185, "start_date": "2011-06", "completion_date": "2011-11", "has_results": true, "last_update_posted_date": "2017-04-27", "last_synced_at": "2026-09-04T03:44:20.177Z", "location_count": 13, "location_summary": "Rancho Mirage, California • Colorado Springs, Colorado • Waterbury, Connecticut + 10 more", "locations": [ { "city": "Rancho Mirage", "state": "California" }, { "city": "Colorado Springs", "state": "Colorado" }, { "city": "Waterbury", "state": "Connecticut" }, { "city": "Clearwater", "state": "Florida" }, { "city": "Pensacola", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT01349816" }, { "nct_id": "NCT01854658", "title": "Multi-Center Study to Assess the Efficacy and Safety of PT003, PT005, and PT001 in Subjects With Moderate to Very Severe COPD (PINNACLE 2)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Chronic Obstructive Pulmonary Disease (COPD)" ], "interventions": [ { "name": "GFF MDI (PT003)", "type": "DRUG" }, { "name": "GP MDI (PT001)", "type": "DRUG" }, { "name": "FF MDI (PT005)", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Pearl Therapeutics, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "40 Years", "maximum_age": "80 Years", "sex": "ALL", "summary": "40 Years to 80 Years" }, "enrollment_count": 1615, "start_date": "2013-07", "completion_date": "2015-03", "has_results": true, "last_update_posted_date": "2017-03-28", "last_synced_at": "2026-09-04T03:44:20.177Z", "location_count": 113, "location_summary": "Birmingham, Alabama • Florence, Alabama • Jasper, Alabama + 110 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Florence", "state": "Alabama" }, { "city": "Jasper", "state": "Alabama" }, { "city": "Mobile", "state": "Alabama" }, { "city": "Fullerton", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT01854658" }, { "nct_id": "NCT02517047", "title": "Community Empowerment to Pilot a Novel Device for Monitoring Rescue Medication Use in Urban Children With Asthma", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Asthma" ], "interventions": [ { "name": "CareTRx", "type": "DEVICE" } ], "intervention_types": [ "DEVICE" ], "sponsor": "Boston Children's Hospital", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "6 Years", "maximum_age": "17 Years", "sex": "ALL", "summary": "6 Years to 17 Years" }, "enrollment_count": 26, "start_date": "2016-03", "completion_date": "2016-12", "has_results": true, "last_update_posted_date": "2018-06-07", "last_synced_at": "2026-09-04T03:44:20.177Z", "location_count": 1, "location_summary": "Boston, Massachusetts", "locations": [ { "city": "Boston", "state": "Massachusetts" } ], "official_url": "https://clinicaltrials.gov/study/NCT02517047" } ] }